Background. Resistance index (RI) measured by Doppler sonography during the early post-transplant period reflects interstitial oedema within the transplanted kidney. We have prospectively analysed the relationship between RI measured shortly after kidney transplantation (KTx), patient and graft survival, as well as kidney graft function during a 5-year follow-up. Methods. RI was measured at the second to fourth day after KTx in 364 consecutive patients, who were divided into tertiles, according to baseline RI value (Group 1: RI < 0.73, Group 2: RI between 0.73 and 0.85 and Group 3: RI > 0.85). The kidney graft function [estimated glomerular filtration rate (eGFR)] during the follow-up period was calculated according to the Modification of Diet in Renal Disease formula. Results. During the 5-year follow-up period, 23 patients died (2.6 versus 6.5 versus 9.6% in RI tertiles, respectively) and 59 lost their kidney graft (12.1 versus 17.7 versus 18.4%, respectively). Survival analyses showed that the effect of RI was significant for a combined outcome [graft loss or death; hazard ratio (HR) ¼ 10.88] and in relation to death, it was of borderline significance (HR ¼ 45.3, P ¼ 0.09). The effect of delayed graft function (DGF) was only significant on graft loss (HR ¼ 1.73). eGFR in the highest tertile was lower than in the lowest tertile during the entire follow-up period. Conclusions. High RI values measured in segmental arteries in the very early post-transplant period predict worse kidney graft function and increased risk of all-cause graft loss, including patient death in the 5-year follow-up period. (ii) The predictive value of RI is not completely independent from the adverse influence of DGF on the premature graft loss.
Introduction
Kidney transplantation (KTx) is the optimal method of treatment in patients with end-stage kidney disease in terms of morbidity, mortality and quality of life [1] . Long-term patient prognosis depends on a well-functioning graft. Many risk factors have been identified that influence a short-and long-term graft survival, such as recipient and donor age, presence of diabetes mellitus, human leukocyte antigen (HLA) mismatch, prolonged cold ischaemia time (CIT), cytomegalovirus infection, acute rejection (AR) episodes and delayed graft function (DGF) [2] [3] [4] . In the early post-transplant period, several important clinical factors may influence kidney graft function, such as vascular complications, rejection episodes and acute immunosuppressive drug toxicity, particularly calcineurin inhibitor toxicity.
Ultrasound Doppler measurement of intrarenal blood flow in the transplanted kidney helps to establish the cause of kidney graft dysfunction [5, 6] . The resistance index (RI), measured in the segmental arteries of the kidney graft within the first days after KTx, reflects the degree of interstitial oedema in the course of ischaemia/reperfusion injury. Remarkably higher RI values were previously reported in patients with delayed kidney graft function [6] . On the other hand, kidney function within the first year after transplantation is an important factor influencing the long-term graft survival [4, 7, 8] . Moreover, Radermacher et al. [9] suggested that an RI value of !0.8 at least 3 months after transplantation is associated with poor subsequent allograft performance and higher risk of death. However, the relationship between intrarenal RI measured shortly after KTx and the long-term graft prognosis remains unclear. In the previously published reports confirming the RI predictive value for long-term graft survival, the defined time of Doppler examination varies widely from the first week [5] , first month [10, 11] and a period between the third and sixth month after transplant [12] . Therefore, we have performed a prospective study to analyse the influence of RI measured 2-4 days after successful KTx on patients and graft survival and kidney graft function during the 5-year follow-up period.
Materials and methods
Three hundred and ninety-four consecutive adult kidney transplant recipients operated on in our centre between January 1998 and December 2004 were studied. Thirty patients were excluded from the analysis: patients diagnosed with an episode of acute humoural rejection at the time of first Doppler examination (n ¼ 10), with primary graft nonfunction (n ¼ 15) and those without Doppler examination performed (n ¼ 5). No patient was diagnosed with transplant renal artery stenosis within the first week after KTx.
The majority of patients was followed in our outpatient clinic. Thus, their clinical data were prospectively collected using a centre-operated statistical database. The long-term follow-up data of patients transferred to other transplant centres were collected retrospectively, in an effort to increase the completeness of follow-up. The institutional review committee approved the study protocol; written consent was not deemed necessary.
In the 364 patients left, the causes of chronic renal disease were as following: chronic glomerulonephritis (61.5%), interstitial nephritis (9.9%), polycystic kidney disease (8.5%), diabetic nephropathy (4.1%), hypertensive nephropathy (3.8%) and other diseases and unknown conditions (12.2%).
Most of the patients received triple immunosuppression therapy, consisting of cyclosporine or tacrolimus, mycophenolate mofetil or azathioprine or sirolimus and steroids (Table 1) . Forty patients received basiliximab (Simulect Ò ; Novartis, Basel, Switzerland) as an induction therapy.
In all patients, the first Doppler sonography of the kidney graft was performed between the second and fourth days post-transplantation. All Doppler examinations were performed by three experienced sonographers with an Acuson machine (Aspen, Mountain View, CA), equipped with 2.5-4.0 MHz micro-convex-array transducer. In each patient, after visualization of three to five segmental arteries, the Doppler spectrum was recorded and analysed. During the examination, patients were asked to refrain from forced inspiration since this could modify the intra-abdominal pressure. The peak systolic velocity (V max ) and end diastolic velocity (V min ) were measured-; the kidney segmental arterial RI was calculated as [RI ¼ 1À(V min /V max )]. Results from two or three measurements were averaged.
Serum creatinine concentration was measured by an automated method (Synchron Cx-7 delta, Cx-5 and Cx-9, all Beckman Coulter Inc., Fullerton, CA). Cyclosporine and tacrolimus blood concentrations were assessed by radioimmunoassay (Immunotech, Prague, Czech Republic) and microparticle enzyme immunoassay (Abbott Laboratories, Abbott Park, IL), respectively.
Initial graft function was defined as immediate graft function (IGF), slow graft function (SGF) and DGF. IGF was defined as the serum creatinine concentration (S Cr ) at Day 3 post-transplant 264 lmol/L (3 mg/dL), SGF was defined as S Cr > 264 lmol/L at Day 3 and DGF was defined as a need of dialysis therapy during the first week after transplantation.
Early AR episode was defined by AR occurrence within the 3 months post-transplant, and late AR when AR was diagnosed later than 3 months after KTx. AR episodes were diagnosed based on clinical signs and symptoms and/or biopsy proven if the diagnosis was uncertain. The kidney graft function during the follow-up period was estimated using the estimated glomerular filtration rate (eGFR) calculated according to the Modification of Diet in Renal Disease formula 3 months after transplantation and every consecutive 6 months.
Data analysis was performed using procedures available in the 9.1.3 SAS statistical package (SAS Institute Inc., Cary, NC). Distribution of quantitative variables was shown by mean values and 95% confidence intervals (CIs) and with qualitative variables by absolute and relative frequencies. Statistical significance of between-group differences was evaluated by analysis of variance (quantitative variables) and chi square test (qualitative variables). All subjects were divided into three groups, according to their baseline values of RI. The groups (tertiles) were defined by RI cut-off values reflecting the 33rd and 66th percentiles of RI distribution. Increasing occurrence of survival outcomes (graft loss, death, graft loss or death) in three groups of increasing values of baseline RI was examined by Cochran-Armitage test for a statistical significance of a trend. Survivor functions and survival curves were obtained by the Kaplan-Meier method (PROC LIFETEST-SAS). Equality of survival profiles over three RI categories was examined by log-rank test. Multivariate regression analysis of survival data was performed using the Cox proportional hazards model (PROC PHREG-SAS). Separate effects were estimated for each outcome (dependent variable): graft loss, death, graft loss or death. Each analysis involved the same candidate independent variables: RI, DGF, recipient's age, donor's age, mismatch HLA-I and mismatch HLA-II. First, a set of simple analyses estimated the effect of single independent variable on either outcome. Composition of the final fixed multivariate model included those independent variables that did not show strong between-variables associations, as examined by analysis of correlation for quantitative and chi square test for qualitative explanatory variables. Interpretation of the results was based on P-values of regression coefficients (parameter), the values of respective hazard ratios (HRs) and their 95% CI. In all statistical tests, the 'P'-values <0.05 were considered statistically significant, however, for multivariate analyses 'P'-value between 0.05 and <0.1 was interpreted as borderline statistical significance.
Results
The demographic characteristics of patients in three study groups (tertiles) are shown in Table 1 . The 5-year followup data were available for 361 of 364 patients (99.2%).
The value of RI ranged between 0.50 and 1.0 (mean: 0.79, SD: 0.10). One hundred and fifteen subjects had an RI < 0.73 (31.8%)-Group 1, 124 an RI between 0.73 and 0.85 (34.0%)-Group 2 and 125 an RI > 0.85 (34.2%)-Group 3. The group of patients with an RI < 0.73 was characterized by slightly lower body mass index, but higher initial dose of cyclosporine. Moreover, this group received kidney grafts from younger donors. The largest difference between these groups was the incidence of DGF: 21.7% in Group 1, 41.9% in Group 2 and 65.6% in Group 3 (P < 0.001). However, there was no difference (P ¼ 0.48) in DGF time span [13 (9-17) versus 15 (13-17) versus 15 (14-17) days, respectively]. The incidence of IGF also differed significantly, with the highest percentage in Group 1 (38.3%), lower in Group 2 (15.3%) and the lowest in Group 3 (6.4%), P < 0.001. There was significantly lower incidence of SGF in Group 3 (P ¼ 0.02 versus Group 2). The incidence of AR episodes was similar in all groups (early AR: 13.9 versus 15.3 versus 21.8%; P ¼ 0.22, late AR: 8.3 versus 12.5 versus 11.2%; P ¼ 0.59, respectively). During the entire follow-up period 59 patients lost their graft, and 23 died. A combined outcome (either death or graft loss) occurred in 82 patients. Figure 1 shows that in subsequent RI groups, the trend for death was statistically significant (P ¼ 0.01), whereas the trend for graft loss did not reach statistical significance (P ¼ 0.09). However, for a combined outcome, the increasing trend was also statistically significant (P ¼ 0.006).
Thirty-four graft losses (21.4%) occurred in patients with DGF and 25 (12.2%) in patients with IGF or SGF (P ¼ 0.03). The incidence of deaths was not statistically different between these groups [12 (7.6%) versus 11 (5.4%), respectively, P ¼ 0.53]. Figure 2 shows the survival curves obtained for each examined outcome, according to the baseline RI category. In three groups of increasing RI, the mean survival time until graft loss was 52.2 (SE: 1.2), 48.3 (SE: 1.0) and 52.6 (SE: 1.6) months, respectively (P ¼ 0.3), until death 50.1 (SE: 0.3), 58.4 (SE: 0.7) and 52.0 (SE: 0.8) months, respectively (P ¼ 0.04) and until the combined outcome (death/graft loss) 51.9 (SE: 1.2), 52.9 (SE: 1.4) and 50.0 (SE: 1.7) months, respectively (P ¼ 0.04).
The effect of RI on survival in relation to three defined outcomes was estimated by the Cox method. The candidate explanatory variables included baseline value of RI and potential confounders: graft recipient's age and gender, 1226 A. Kolonko et al.
diagnosis of diabetes and hypertension, CIT, donor's age, mismatch HLA-I, mismatch HLA-II and DGF. Results of simple survival analyses (one independent variable in a model) showed that graft survival was associated with recipient's age (P ¼ 0.04), donor's age (P ¼ 0.04), DGF (P ¼ 0.005) but not with RI (P ¼ 0.1), mismatch HLA-I (P ¼ 0.5) or mismatch HLA-II (P ¼ 0.6). Patient survival was dependent on recipient's age (P ¼ 0.006), RI (P ¼ 0.04) and not on donor's age (
The composed outcome (death or graft loss) was explained by donor's age (P ¼ 0.005), RI (P ¼ 0.02), DGF (P ¼ 0.01) and not by recipient's age (P ¼ 0.7) or gender (P ¼ 0.6), diagnosis of diabetes (P ¼ 0.9) or hypertension (P ¼ 0. The final description of explored effects was provided by the fixed multivariate models with recipient's age, donor's age, mismatch HLA-I, mismatch HLA-II as confounding variables, chosen because of their potential biological meaning. Apart from the confounders, the models included either RI or DGF because of their strong correlation (P < 0.001). Table 2 shows the results separately for a fixed model with RI and for a fixed model with DGF. Results of parallel survival analyses showed that after adjustment for confounding variables, the effect of RI was statistically significant for a combined outcome (graft loss or death; HR ¼ 10.88, P ¼ 0.02), and in relation to death, it was of borderline statistical significance (HR ¼ 45.3, P ¼ 0.09). On the other hand, the effect of DGF was statistically significant on graft loss (HR ¼ 1.73, P < 0.05). When RI was transformed into class variable (three above defined categories), the statistical conclusions from Cox analysis did not change (results not shown).
We have also analysed the glomerular filtration rate during the 5-year follow-up period. In all time points, eGFR was significantly higher in patients who had RI values <0.73 as compared with those with initial RI values >0.85 (Figure 3 ). The mean difference in eGFR between these groups diminished from 12.3 mL/min/1.73m 2 at 3 months after KTx to 6.5 mL/min/1.73m 2 after 60 months, respectively. The analysis of the eGFR slopes in the defined tertiles groups did not revealed significant difference: À3.84 (À5.91 to À1.77) mL/ year versus À5.73 (À8.18 to À3.27) mL/year versus À3.19 (À4.58 to À1.80) mL/year.
Discussion
The most important finding in our study is that high RI value found in the first days after KTx can predict the worse graft function during long-term observation and higher risk of all-cause graft loss, including patient death. We believe that this information is profound for several reasons. Firstly, prognostic indicators days after KTx are always clinically important. Secondly, conceivably, we identified those kidneys sorely in need of novel therapies to improve outcomes.
There is a great need for a reliable marker that can predict long-term kidney graft function. A variety of clinical signs and biochemical parameters have been proposed. Some reports suggest that post-transplant kidney graft function within a few days after transplantation, measured by serum creatinine or calculated as creatinine reduction ratio, correlates with long-term graft survival [3, 13, 14] , while others did not confirm these results [15] . Mun Woo et al. concluded that a serum creatinine of <200 lmol/L at 3 months after KTx had a predictive value for a better long-term patient survival and in the absence of AR episodes it was also associated with better graft survival [16] . Hariharan et al. [7] have analysed 105 742 kidney graft recipients Fig. 2 . The survival curves for patients in three groups, based on initial RI value; on upper chart: patients survival; on medium chart: graft survival; on lower chart: combined outcome (patient and graft survival). Fig. 1 . The trend for death (dark bars) or graft loss (grey bars) in patients in three subsequent RI groups, based on initial RI value; statistical significance for the trend: for death P ¼ 0.01, for graft loss P ¼ 0.09, for combined outcome P < 0.006.
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A. Kolonko et al. and have demonstrated that 1-year serum creatinine concentration predicts long-term graft survival. Others also confirmed these findings [4, 8] .
A long list of predictors such as donor and recipient age, HLA mismatches, prolonged CIT, body mass index, proteinuria, duration of dialysis therapy prior to KTx, arterial hypertension and diabetes mellitus determined the long-term graft function. However, Radermacher et al. [9] demonstrated that none of these factors was superior as a predictor of kidney graft performance to the value of kidney arterial RI. The authors concluded that an RI value !0.8 measured at least 3 months after transplantation was associated with poor subsequent allograft survival or patients death in the years to come. The clinical value of colour Doppler sonography in kidney transplant patients has been widely recognized [17] [18] [19] .
The relationship between intrarenal RI value measured shortly after KTx and the long-term graft and patient survival remains unclear. To date, to our best knowledge, the only study, which analysed the kidney resistance values obtained as soon as within the first week after KTx 45 patients, demonstrated their predictive value for 1-month and 1-year allograft function [5] . In other follow-up studies, the time of Doppler examinations varied from within the first month [10, 11] , and the period from third to sixth month [9, 12] to few years after KTx [20] . In the present study, we analysed the association between RI measured Fig. 3 . The glomerular filtration rate (eGFR) in patients in three groups, based on initial RI value. Statistical significance: ***P < 0.001; **P < 0.01; *P < 0.05 for patients from group with RI 0.86-1.0 versus group with RI 0.5-0.72. The model with RI and not DGF among independent variables in presented in upper part, while the model with DGF and not RI among independent variables in the lower part of the table.
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shortly after KTx and graft or patient survival and kidney graft function during the 5-year follow-up period. We found that initial RI values have determined the kidney graft function in the early post-transplant period: the incidence of DGF was directly proportional to the initial RI value. Thus, the 58.4% of patients with an RI >0.85 had DGF, while it occurred only in 16.5% of those with an RI value <0.73. The only difference which could explain, to some extent, this observation was the younger donor age and slightly lower body mass index, with higher cyclosporine but not tacrolimus initial dose (Table 1) . Of note, the initial calcineurin inhibitor trough levels did not differ significantly. No other statistically significant differences were noticed between groups, concerning numerous donor-and recipient-dependent factors, including recipient co morbidity, as well as CIT, HLA mismatches and panel-reactive antibodies count. According to several previously published studies, the dominant cause of DGF after KTx is ATN, while AR determines only the minority of DGF cases [21] [22] [23] . Other risk factors found as independent predictors of DGF are the following: prolonged CIT, higher donor age and recipient vascular system status [3, 21, 22] . Some reports confirmed that DGF occurrence is an independent risk factor for 5-year graft loss [13, 22] , while other authors did not confirm such an influence on long-term kidney or patient outcome [21] or suspect that the detrimental effects of DGF are limited only to the first year after transplantation [3] . Troppmann et al. [24] concluded that DGF without concomitant AR has no impact on long-term graft survival, while the worst long-term outcome was noted in the subgroup with both DGF and AR episodes. Finally, the recently published meta-analysis emphasizes and quantifies the long-term detrimental association between DGF and graft outcomes like graft survival, AR and kidney function [25] . Based on these reports, to properly analyse the role of elevated initial RI values in patients with different early kidney graft function, namely in patients with IGF or SGF (non-DGF subgroup) versus patients with DGF (DGF subgroup), we had to take into account that both variables (RI and DGF) are strongly correlated, with RI values usually higher in DGF patients.
Therefore, we performed parallel survival analyses separately for RI and DGF, which showed that while the effect of RI was statistically significant for a combined outcome (graft loss or patients' death), the DGF effect was significant for a graft loss. It is worth noting that in the subsequent three RI groups, we observed that the significant trend for death and borderline trend for graft loss, with the strongest significance (P ¼ 0.006) for the increasing trend for combined outcome. The mechanism which links the higher RI values and patient death is intriguing. An RI > 0.8 has been previously demonstrated to increase the risk of death in stable kidney allograft recipients [9] . Moreover, RI values correlate with the recipient's but not the donor's age [6, 26] , as well as with the pulse wave velocity and intima media thickness [26] . We may hypothetize that an RI value partially reflects the atherosclerotic lesions and remodelling of the recipient's vasculature followed by lower arterial distensibility. In line with this hypothesis, we have recently demonstrated a worse long-term survival of patients with higher initial RI value in paired kidney analysis [27] . Of note, the graft survival was similar in both groups.
The initial RI value was also the predictor of long-term function of surviving kidney grafts. In a whole 5-year follow-up period, the significant difference in eGFR was observed between patients with baseline RI < 0.73 and RI > 0.85, even though this difference was diminished over the years. We are unable to explain the steeper slope of eGFR decline in the group of patients with the lowest initial RI values as we did not perform protocol biopsies. We did not observe a higher rate of AR episodes in this group.
The limitation of the study is the lack of protocol biopsies that disable an analysis of the structure of DGF and causes of graft function deterioration. Moreover, the somehow limited size of the group weakened the statistical power of the performed analyses. Thus, only multicentre studies performed in the future may overcome this limitation.
We do believe that our study provides some additional perspectives for our patients. We have shown that in patients after KTx, the high RI values (>0.85) measured in segmental arteries of the kidney graft in the early posttransplant period are the predictor of worse kidney graft function and all-cause graft loss, including patient death, however, it is not completely independent from DGF. The challenge now lies in developing sensible intervention procedures for those patients who did not do so well in terms of their RI value.
